Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The collaboration between CORONA and Ferring will cater to patients across India
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
Subscribe To Our Newsletter & Stay Updated
